| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/29/1994 | EP0604184A1 Inhibitors of HIV protease useful for the treatment of aids |
| 06/29/1994 | EP0604182A2 Inhibitors of HIV protease useful for the treatment of Aids |
| 06/29/1994 | EP0604143A2 Rapamycin loaded formed blood elements to induce immunosuppression |
| 06/29/1994 | EP0603887A2 Bicyclic amine derivatives |
| 06/29/1994 | EP0603755A2 Cephalosporin salts and processes for their preparation |
| 06/29/1994 | EP0603649A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors |
| 06/29/1994 | EP0603386A1 Parenteral immunization against rotavirus |
| 06/29/1994 | EP0603309A1 Peptide isoters containing a heterocycle as h.i.v. inhibitors |
| 06/29/1994 | EP0603303A1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 06/29/1994 | EP0603251A1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions |
| 06/29/1994 | CN1088583A Phospholipi derivatives containing higher elements of the Vth main group |
| 06/29/1994 | CN1088432A Beads having a core coated with an antifungal and a polymer |
| 06/29/1994 | CN1025199C 3-deoxy mycaminosyl tylonlide derivatives and the prepn. |
| 06/29/1994 | CN1025193C Process for preparing antifungal triazolones and imidazolones derivs. |
| 06/29/1994 | CN1025192C Azabicyclo quinolone carboxylic acids and the prepn. method therefor |
| 06/28/1994 | US5324740 For treating fungal diseases or estrogen-dependent disorders |
| 06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
| 06/28/1994 | US5324721 3-Substituted cephalosporins, and their use as medicaments |
| 06/28/1994 | US5324716 Microbiocidal oligopeptide for use in human or animal therapy, fungicides, viricides, disinfectants or food preservation |
| 06/28/1994 | US5324511 Contain a single flagellar (H) antigen of serotype a or a combination with an antigen of serotype b; inhibit motility of pathogens |
| 06/25/1994 | CA2112196A1 Cephalosporin salts and process for the preparation thereof |
| 06/24/1994 | CA2112047A1 Antiretroviral hydrazine derivatives |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013801A1 Mammalian receptors for interleukin-10 (il-10) |
| 06/23/1994 | WO1994013793A1 Compounds and methods for the treatment of leukemias |
| 06/23/1994 | WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 06/23/1994 | WO1994013687A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 06/23/1994 | WO1994013682A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| 06/23/1994 | WO1994013649A1 Tropone-substituted phenyloxazolidinone antibacterial agents |
| 06/23/1994 | WO1994013314A1 Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors |
| 06/23/1994 | WO1994013295A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 06/23/1994 | WO1994013143A1 Stabilized lanthionine bacteriocin compositions |
| 06/23/1994 | WO1994003467A3 Antiretroviral enantiomeric nucleotide analogs |
| 06/23/1994 | CA2150903A1 Compounds for the treatment of leukemias |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2112052A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112043A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112042A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112038A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112019A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2110939A1 An innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 06/22/1994 | EP0603031A2 Antiviral antibiotic BU-4724V and preparation thereof |
| 06/22/1994 | EP0603030A2 Antiviral antibiotic BU-4628V and preparation thereof |
| 06/22/1994 | EP0602761A1 Prevention and treatment of retroviral disease |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602306A1 Retroviral protease inhibitors |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602069A1 Retroviral protease inhibitors |
| 06/22/1994 | EP0545951B1 Hrsv vaccine |
| 06/22/1994 | EP0409895B1 A pasteurella vaccine |
| 06/22/1994 | CA2111778A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
| 06/21/1994 | US5322858 Antimicrobial, antiparasitic agents |
| 06/21/1994 | US5322854 Antibiotic |
| 06/21/1994 | US5322689 Copolymer of acrylic acid and fatty alcohol acrylate ester crosslinked with polyalkenyl polyether of polyhydric alcohol, volatile aromatic compound |
| 06/21/1994 | CA1330305C Heparin fragments and fractions with anti-hiv action |
| 06/21/1994 | CA1330303C Composition and process to enhance the efficacy of a fish vaccine |
| 06/17/1994 | CA2111454A1 Retroviral protease inhibitors |
| 06/15/1994 | EP0601573A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method |
| 06/15/1994 | EP0601486A1 Cis-epoxide derivatives useful as irreversible HIV protease inhibitors and process and intermediates for their preparation |
| 06/15/1994 | EP0601417A2 Physiologically compatible and degradable polymer-based carbohydrate receptor blockers, a method for their preparation and their use |
| 06/15/1994 | EP0601108A1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/15/1994 | EP0441832B1 Composition and treatment with biologically active peptides and certain anions |
| 06/15/1994 | EP0357693B1 Molecular sieve arrangement |
| 06/15/1994 | CN1087913A Rapamycin derivatives |
| 06/15/1994 | CN1087912A Rapamycin derivatives |
| 06/15/1994 | CN1087911A Rapamycin derivatives |
| 06/15/1994 | CN1087899A 9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 06/15/1994 | CN1087778A A method for preparing low free formaldehyde methylolhydantoins and compositions thereof |
| 06/15/1994 | CN1025032C Process for preparing 2-methoxymethyl-penem derivatives |
| 06/15/1994 | CN1025002C Therapeutical compositions against psoriasis |
| 06/15/1994 | CA2110854A1 Antiviral antibiotic bu-4628v and preparation thereof |
| 06/15/1994 | CA2110827A1 Antiviral antibiotic bu-4724v and preparation thereof |
| 06/14/1994 | US5321141 Reacting an isothiazole with an a,b-unsaturated ketone or aldehyde |
| 06/14/1994 | US5321042 Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation |
| 06/14/1994 | US5321030 Administering for treatment or prevention |
| 06/14/1994 | US5320947 Immune reactivity to expressed activated oncogenes for diagnosis of malignancy |
| 06/14/1994 | US5320849 Anti-virus agent |
| 06/14/1994 | US5320840 Continuous release pharmaceutical compositions |
| 06/12/1994 | CA2111129A1 Physiologically tolerated and physiologically degradable polymer-based carbohydrate receptor blocker, a process for its preparation and its use |
| 06/10/1994 | CA2109771A1 .alpha.-phosphonocarboxylate squalene synthetase inhibitors |
| 06/09/1994 | WO1994012880A2 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/09/1994 | WO1994012641A1 Haemophilus outer membrane protein |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012528A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | WO1994012517A1 Sequence-specific binding polymers for duplex nucleic acids |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012461A1 Catechol diethers as selective pdeiv inhibitors |
| 06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | WO1994012188A1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 06/09/1994 | WO1994012165A2 Enzyme inhibitors |
| 06/09/1994 | WO1994012156A1 Antibiotic formulation and use for drug resistant infections |
| 06/09/1994 | WO1994012155A1 Antibiotic formulation and process |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | CA2400368A1 Catechol diethers as selective pde iv inhibitors |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |